Trial · NCT03466346
Participant flow30
How many started, completed or left each group, period by period.
1 to 20 of 30
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Stage 1 - 1st Line Trt (IPT or FLX) | STARTED | Stage 1: Interpersonal Psychotherapy | 1,082 | |
| Stage 1 - 1st Line Trt (IPT or FLX) | STARTED | Stage 1: Fluoxetine | 1,080 | |
| Stage 1 - 1st Line Trt (IPT or FLX) | STARTED | Stage 2: IPT After Fluoxetine | 0 | |
| Stage 1 - 1st Line Trt (IPT or FLX) | STARTED | Stage 2: Fluoxetine After IPT | 0 | |
| Stage 1 - 1st Line Trt (IPT or FLX) | STARTED | Stage 2: IPT and Fluoxetine | 0 | |
| Stage 1 - 1st Line Trt (IPT or FLX) | COMPLETED | Stage 1: Interpersonal Psychotherapy | 986 | |
| Stage 1 - 1st Line Trt (IPT or FLX) | COMPLETED | Stage 1: Fluoxetine | 878 | |
| Stage 1 - 1st Line Trt (IPT or FLX) | COMPLETED | Stage 2: IPT After Fluoxetine | 0 | |
| Stage 1 - 1st Line Trt (IPT or FLX) | COMPLETED | Stage 2: Fluoxetine After IPT | 0 | |
| Stage 1 - 1st Line Trt (IPT or FLX) | COMPLETED | Stage 2: IPT and Fluoxetine | 0 | |
| Stage 1 - 1st Line Trt (IPT or FLX) | NOT COMPLETED | Stage 1: Interpersonal Psychotherapy | 96 | |
| Stage 1 - 1st Line Trt (IPT or FLX) | NOT COMPLETED | Stage 1: Fluoxetine | 202 | |
| Stage 1 - 1st Line Trt (IPT or FLX) | NOT COMPLETED | Stage 2: IPT After Fluoxetine | 0 | |
| Stage 1 - 1st Line Trt (IPT or FLX) | NOT COMPLETED | Stage 2: Fluoxetine After IPT | 0 | |
| Stage 1 - 1st Line Trt (IPT or FLX) | NOT COMPLETED | Stage 2: IPT and Fluoxetine | 0 | |
| Stage 2 - 2nd Line Trt (Combo or Switch) | STARTED | Stage 1: Interpersonal Psychotherapy | 0 | |
| Stage 2 - 2nd Line Trt (Combo or Switch) | STARTED | Stage 1: Fluoxetine | 0 | |
| Stage 2 - 2nd Line Trt (Combo or Switch) | STARTED | Stage 2: IPT After Fluoxetine | 68 | |
| Stage 2 - 2nd Line Trt (Combo or Switch) | STARTED | Stage 2: Fluoxetine After IPT | 104 | |
| Stage 2 - 2nd Line Trt (Combo or Switch) | STARTED | Stage 2: IPT and Fluoxetine | 160 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03466346/flow